Detalhe da pesquisa
1.
Five-year survival follow-up of a phase III randomised trial comparing ofatumumab versus physicians' choice for bulky fludarabine-refractory chronic lymphocytic leukaemia: a short report.
Br J Haematol
; 189(4): 689-693, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31994178
2.
The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial.
Haematologica
; 105(6): 1552-1558, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31467130
3.
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(9): 1947-1951, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29793046
4.
TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation.
Br J Haematol
; 172(6): 914-22, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26771088
5.
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Blood
; 123(19): 2960-7, 2014 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-24652988
6.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31413097
7.
Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial.
Br J Haematol
; 184(5): 833-836, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29528122
8.
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
Blood
; 120(12): 2521-8, 2012 Sep 20.
Artigo
Inglês
| MEDLINE | ID: mdl-22855604
9.
Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.
Blood
; 129(18): 2587-2591, 2017 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28258055
10.
The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controls.
Br J Haematol
; 181(1): 148-151, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28106906
11.
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
Br J Haematol
; 161(2): 237-44, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23432431
12.
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.
Blood Adv
; 7(13): 2994-3004, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36689727
13.
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.
Haematologica
; 102(11): e460-e464, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28838995
14.
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Blood Adv
; 6(6): 1941-1946, 2022 03 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35008107
15.
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Blood Adv
; 6(11): 3294-3303, 2022 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35320339
16.
Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD.
Front Oncol
; 12: 862991, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35387132
17.
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
J Hematol Oncol
; 15(1): 126, 2022 09 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36064577
18.
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
Blood Adv
; 6(5): 1394-1405, 2022 03 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34794176
19.
Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination - A Case Report.
TH Open
; 5(3): e315-e318, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34377889
20.
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
Blood Adv
; 5(17): 3279-3289, 2021 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34459887